Patents Assigned to Anergis, S.A.
  • Contiguous overlapping peptides for treatment of ragweed pollen allergy
    Patent number: 9005627
    Abstract: Contiguous overlapping peptides (COPs) for the treatment of allergic patients by Specific Immunotherapy (SIT) are provided from the sequence of the major allergen of ragweed pollen Amb a 1. Such peptides while providing all potential T cell epitopes are devoid of the three-dimensional structure of the original allergen, therefore reducing their ability to bind IgE.
    Type: Grant
    Filed: June 26, 2012
    Date of Patent: April 14, 2015
    Assignee: Anergis S.A.
    Inventors: Christophe Reymond, Francois Spertini
  • Allergen peptide fragments and use thereof for treatment of dust mite allergies
    Patent number: 8703144
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: April 22, 2014
    Assignee: Anergis S.A.
    Inventors: Francois Spertini, Blaise Corthesy
  • Contiguous overlapping peptides for treatment of birch pollen allergy
    Patent number: 8343503
    Abstract: Contiguous overlapping peptides (COPs) for the treatment of allergic patients by Specific Immunotherapy (SIT) are provided from the sequence of the major allergen of birch pollen Bet v 1. Such peptides while providing all potential T cell epitopes are devoid of the 3D structure of the original allergen, therefore reducing their ability to bind IgE.
    Type: Grant
    Filed: February 9, 2010
    Date of Patent: January 1, 2013
    Assignee: Anergis S.A.
    Inventors: Christophe Reymond, Francois Spertini
  • Allergen peptide fragments and use thereof
    Patent number: 8075897
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Grant
    Filed: September 14, 2005
    Date of Patent: December 13, 2011
    Assignee: Anergis S.A.
    Inventors: Francois Spertini, Blaise Corthesy
  • Allergen peptide fragments and use thereof
    Patent number: 7923209
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: April 12, 2011
    Assignee: Anergis, S.A.
    Inventors: Francois Spertini, Blaise Corthesy